Percentile | Time from first presentation to diagnosis | Model estimates | ||||
2017–2019 (days, 95% CI) | 2020 (days, 95% CI) | Unadjusted (days, 95% CI) | P value | Adjusted* (days, 95% CI) | P value | |
Any cancer (n=215) | ||||||
25th | 8 (5 to 10) | 6 (3 to 14) | −2 (−9.9 to +5.9) | 0.6 | +3.6 (−6.1 to +8.1) | 0.8 |
50th | 23 (11 to 29) | 29 (13 to 50) | +7 (−18.1 to 32.7) | 0.6 | +4.5 (−20.5 to +29.5) | 0.5 |
75th | 64 (57 to 80) | 69 (42 to 105) | +5 (−16.7 to +26.7) | 0.8 | +8.3 (−15.7 to +42.2) | 0.4 |
Haematological cancers (n=84) | ||||||
25th | 6 (3 to 14) | 4 (1 to 12) | −2 (−9.5 to +5.51) | 0.8 | −1 (−23.3 to +21.3) | 0.9 |
50th | 20 (11 to 30) | 13 (4 to 57) | −6 (−39.2 to +27.2) | 0.7 | −6.5 (−29.1 to +16.1) | 0.6 |
75th | 72 (32 to 110) | 60 (17 to 106) | −10 (−77.7 to +57.7) | 0.5 | −12 (−45.2 to +21.2) | 0.5 |
Solid cancers (n=131) | ||||||
25th | 9 (6 to 14) | 13 (1 to 12) | +5 (−4.0 to +14.0) | 0.5 | +6 (−10.1 to +22.1) | 0.2 |
50th | 23 (19 to 42) | 31 (15 to 72) | +9 (−26.4 to +44.4) | 0.6 | +8 (−26.3 to +42.3) | 0.6 |
75th | 64 (57 to 79) | 83 (39 to 128) | +14 (−30.2 to +58.3) | 0.8 | −10 (−54.6 to +34.7) | 0.7 |
*Adjusted for age, sex, deprivation level for haematological and solid cancers; adjusted for age, sex, deprivation level and tumour type for all cancers.
CTYA, childhood, teenage and young adult.